IP Library Granted Patent US 10,232,180
Granted Patent B2
US 10,232,180 · App. 15/861,592 · Granted Mar 19, 2019

Selective stimulation to modulate the sympathetic nervous system

Inventors: Jeffery M. Kramer (San Francisco, CA); Daniel H. Kim (Houston, TX); Mir A. Imran (Los Altos, CA)
Assignees: The Board of Trustees of the Leland Stanford Junior University; St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)
A61N1/36114A61N1/0551A61N1/36057A61N1/36071A61N1/36135
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,232,180
App. No.
15/861,592
Granted
Mar 19, 2019
Kind
B2
Abstract

Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.

Claims (21)

1. A method of treating a condition or disorder in a patient necessitating weight control, comprising:

implanting a first stimulation lead with at least one electrode positioned to selectively stimulate a dorsal root ganglion (DRG) in the patient;

implanting a second stimulation lead with at least one electrode positioned to stimulate neural tissue of a sympathetic chain of the patient that is downstream from the DRG wherein the neural tissue of the sympathetic chain of the patient is selected from the group consisting of: a celiac ganglion, an interior mesenteric ganglion, and a superior mesenteric ganglion; and

applying electrical stimulation, from at least one implantable pulse generator and using the first and second stimulation leads, to the DRG and to the neural tissue of the sympathetic chain to selectively modulate gastric motility and hunger in the patient and to modulate hormonal regulation to treat the condition or disorder of the patient necessitating weight control.

2. The method of treating a condition or disorder in a patient necessitating weight control according to claim 1 wherein after performing the implanting a first stimulation lead step the first stimulation lead is positioned to selectively stimulate a dorsal root ganglion within a thoracic vertebral level of a spine of the patient.

3. The method of treating a condition or disorder in a patient necessitating weight control according to claim 2 wherein after performing the implanting a second stimulation lead step the second stimulation lead is positioned to stimulate neural tissue of the sympathetic chain of the patient comprising a ganglion of the sympathetic chain within a thoracic vertebral level of a spine of the patient.

4. The method of treating a condition or disorder in a patient necessitating weight control according to claim 3 wherein the ganglion of the sympathetic chain is one of a celiac ganglion and a superior mesenteric ganglion.

5. The method of treating a condition or disorder in a patient necessitating weight control according to claim 1 wherein after performing the implanting a first stimulation lead step the first stimulation lead is positioned to selectively stimulate a dorsal root ganglion within a lumbar vertebral level of a spine of the patient.

6. The method of treating a condition or disorder in a patient necessitating weight control according to claim 5 wherein after performing the implanting a second stimulation lead step the second stimulation lead is positioned to stimulate neural tissue of the sympathetic chain of the patient comprising a ganglion of the sympathetic chain within a lumbar vertebral level of a spine of the patient.

7. The method of treating a condition or disorder in a patient necessitating weight control according to claim 6 wherein the ganglion of the sympathetic chain is an interior mesenteric ganglion.

8. The method of treating a condition or disorder in a patient necessitating weight control according to claim 1 wherein after performing the implanting a first stimulation lead step the first stimulation lead is positioned to selectively stimulate a dorsal root ganglion on a first thoracic vertebral level of a spine of the patient; and implanting a third stimulation lead with at least one electrode positioned to selectively stimulate a dorsal root ganglion (DRG) in the patient on a second thoracic vertebral level of a spine of the patient.

9. The method of treating a condition or disorder in a patient necessitating weight control according to claim 1 wherein after performing the implanting a first stimulation lead step the first stimulation lead is positioned to selectively stimulate a dorsal root ganglion on a first lumbar vertebral level of a spine of the patient; and

implanting a third stimulation lead with at least one electrode positioned to selectively stimulate a dorsal root ganglion (DRG) in the patient on a second lumbar vertebral level of a spine of the patient.

10. The method of treating a condition or disorder in a patient necessitating weight control according to claim 1 wherein after performing the implanting a first stimulation lead step the first stimulation lead is positioned to selectively stimulate a dorsal root ganglion on a first side of a thoracic vertebral level of a spine of the patient; and implanting a third stimulation lead with at least one electrode positioned to selectively stimulate a dorsal root ganglion (DRG) in the patient on a second side of the thoracic vertebral level of a spine of the patient.

11. The method of treating a condition or disorder in a patient necessitating weight control according to claim 1 wherein after performing the implanting a first stimulation lead step the first stimulation lead is positioned to selectively stimulate a dorsal root ganglion on a first side of a lumbar vertebral level of a spine of the patient; and implanting a third stimulation lead with at least one electrode positioned to selectively stimulate a dorsal root ganglion (DRG) in the patient on a second side of the lumbar vertebral level of a spine of the patient.

12. The method of treating a condition or disorder in a patient necessitating weight control according to claim 1 wherein after performing the implanting a first stimulation lead and implanting the second stimulation lead steps the first stimulation lead and the second stimulation lead are implanted on the same side of the spine of the patient.

13. The method of treating a condition or disorder in a patient necessitating weight control according to claim 12 wherein after performing the implanting a first stimulation lead and implanting the second stimulation lead steps the first stimulation lead and the second stimulation lead are implanted on the same spinal level of the spine of the patient.

14. The method of treating a condition or disorder in a patient necessitating weight control according to claim 12 wherein after performing the implanting a first stimulation lead and implanting the second stimulation lead steps the first stimulation lead and the second stimulation lead are implanted on different spinal levels of the spine of the patient.

15. The method of treating a condition or disorder in a patient necessitating weight control according to claim 1 wherein after performing the implanting a first stimulation lead and implanting the second stimulation lead steps the first stimulation lead and the second stimulation lead are implanted on different sides of the spine of the patient.

16. The method of treating a condition or disorder in a patient necessitating weight control according to claim 15 wherein after performing the implanting a first stimulation lead and implanting the second stimulation lead steps the first stimulation lead and the second stimulation lead are implanted on the same spinal level of the spine of the patient.

17. The method of treating a condition or disorder in a patient necessitating weight control according to claim 15 wherein after performing the implanting a first stimulation lead and implanting the second stimulation lead steps the first stimulation lead and the second stimulation lead are implanted on different spinal levels of the spine of the patient.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2023
From: ST. JUDE MEDICAL LUXEMBOURG HOLDINGS SMI S.A.R.L. ("SJM LUX SMI")
To: TC1 LLC
Reel/Frame 064903/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2019
From: KIM, DANIEL H.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 047885/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2019
From: KRAMER, JEFFERY M.; IMRAN, MIR A.
To: SPINAL MODULATION, INC.
Reel/Frame 047885/0254 →
CHANGE OF NAME Recorded Jan 2, 2019
From: SPINAL MODULATION, INC.
To: SPINAL MODULATION LLC
Reel/Frame 047885/0262 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2019
From: SPINAL MODULATION LLC
To: ST. JUDE MEDICAL LUXEMBOURG HOLDINGS SMI S.A.R.L. ("SJM LUX SMI")
Reel/Frame 047885/0277 →
Continuity (8)
Continuation 15346587 · Nov 8, 2016
Continuation 14954740 · Nov 30, 2015
Continuation 13458697 · Apr 27, 2012
Continuation In Part 12369706 · Feb 11, 2009
Division 11222516 · Sep 7, 2005
Provisional Application 61480958 · Apr 29, 2011
Provisional Application 60608357 · Sep 8, 2004
Related Publication 20180126166A1 · May 10, 2018
Cited By (6)
US 12,226,634 US 12,343,537 US 12,408,974 US 12,420,098 US 12,478,806 US 12,539,167